A Prognostic Study for Patients With Cardiovascular Disease in Niigata

May 19, 2025 updated by: Niigata University Medical & Dental Hospital

A Prognostic Study Using Health Insurance Claim for Patients With Cardiovascular Disease in Niigata

The goal of this observational study is to investigate the prognosis of cardiovascular disease in Niigata Prefecture.

Specifically, it aims to clarify the current status of medical treatment for cardiovascular disease patients in regional cities in Japan, where the population is aging.

With patient consent, the study will track long-term medical treatment progress using health insurance claim data recorded in Japan's unique social security system.

Study Overview

Status

Enrolling by invitation

Conditions

Study Type

Observational

Enrollment (Estimated)

8500

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Japan
      • Niigata, Japan, 951-8114
        • Niigata University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Eligible participants are individuals aged 18 or older who have been hospitalized in the cardiology department of a participating medical institution and are covered by Japan's National Health Insurance or the Late-stage Elderly Medical Care System

Description

Inclusion Criteria:

  • Individuals aged 18 or older at the time of enrollment (regardless of gender).
  • Individuals who have been hospitalized in the cardiology department of a participating medical institution.
  • Individuals covered by Japan's National Health Insurance (NHI) or the Late-stage Elderly Medical Care System, which provide health coverage for self-employed individuals, retirees, and the elderly.

Exclusion Criteria:

  • Individuals who are unable to obtain consent from themselves or their legally authorized representatives.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The rate of deterioration in care dependency levels as defined by Japan's Long-Term Care Insurance system
Time Frame: through study completion, an average of 1 year
through study completion, an average of 1 year
through study completion, an average of 1 year

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Niigata University Medical & Dental Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 12, 2025

Primary Completion (Estimated)

December 31, 2047

Study Completion (Estimated)

May 1, 2050

Study Registration Dates

First Submitted

March 5, 2025

First Submitted That Met QC Criteria

May 19, 2025

First Posted (Actual)

May 28, 2025

Study Record Updates

Last Update Posted (Actual)

May 28, 2025

Last Update Submitted That Met QC Criteria

May 19, 2025

Last Verified

May 1, 2025

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2024-0250

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiovascular Diseases

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe